Canada NewsWire
TORONTO , May 9, 2022 /CNW/ - Steve Saviuk , Chief Executive Officer, Frederic Fasano , President and Chief Operating Officer, Luc Mainville , Senior Vice-President and Chief Financial Officer, Valeo Pharma Inc. ("Valeo" or the "Company") (TSX: VPH) and their team joined Daniel Lubienietzky, Manager, Life Sciences, Toronto Stock Exchange, to celebrate the Company's new listing on Toronto Stock Exchange and open the market.
Headquartered in Kirkland, Quebec , Valeo Pharma is a Canadian specialty pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada , with a focus on respirology, neurodegenerative diseases, oncology and other specialty products.
Date: Monday, May 9 , 2022
Time: 9:00am - 9:30am
Place: 120 Adelaide St W.
SOURCE Toronto Stock Exchange
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2022/09/c0042.html